Lexington Biosciences Inc. (LXGTF)

[StockBro75]

"Blood pressure monitor market forecast to exceed $2.6 billion by 2020"
• Historical CAGR of 6.53% from 2012 to 2016
• Increasing prevalence of high and low blood pressure issues in patients
• Market is fragmented and commoditized
• Acquirers seeking high value differentiated features for premium product
offerings
Robust Market Scope and Dynamics
Stats: Global Industry Analysts, Inc.
• HeartSentry initially targeted at the
clinic based professional market, with
the intention to market direct to
consumer pending FDA approval
• Endothelial function monitoring will
increase the demand for high value
connected cardiovascular monitoring
devices
• HeartSentry is marketable both as a
capital investment as well as a pay per
use model
• Potential reimbursement offers revenue
sharing opportunities with clinics